AZZ Inc (NYSE: AZZ) has reported E.P.S. of $1.12 for its third fiscal quarter (ending November 30) versus $0.93 for the same period a year ago — an increase of 20%. E.P.S. were $1.69 for […]
On 1/7/25, Frontline plc (NYSE: FRO) stock enjoyed a major increase of 11.4%, closing at $15.90. Moreover, this advance was accompanied by exceptionally high trading volume at 284% of normal. Relative to the market the […]
AAR Corp (NYSE: AIR) has reported a loss for its second fiscal quarter (ending November 30) of $-0.87 versus $0.67 for the same period a year ago — a decline of -230%. E.P.S. were $0.30 […]
The Chemours Co (NYSE: CC) stock closed at $18.76 on 1/7/25 after a major increase of 10.8%. Moreover, unusually high trading volume at 182% of normal accompanied the advance. The stock has risen 10.3% during […]
Simulations Plus Inc (NASDAQ: SLP) has reported earnings for its first fiscal quarter (ending November 30) of $0.01 versus $0.10 for the same period a year ago — a decline of -90%. E.P.S. were $0.41 […]
For its second fiscal quarter (ending November 30), Cal Maine Foods Inc (NASDAQ: CALM) has reported a 1183% increase in E.P.S. from $0.35 a year ago to $4.49 in the current quarter. E.P.S. were $12.90 […]
For its third fiscal quarter (ending November 30), Apogee Enterprises Inc (NASDAQ: APOG) has reported a -23% decline in E.P.S. from $1.24 a year ago to $0.96 in the current quarter. For the latest four […]
On 1/7/25, Shutterstock Inc (NYSE: SSTK) stock enjoyed a major increase of 14.8%, closing at $34.50. Moreover, exceptionally high trading volume at 947% of normal accompanied the advance. Relative to the market the stock has […]
On 1/7/25, Asure Software Inc (NASDAQ: ASUR) stock enjoyed a major increase of 13.7%, closing at $11.37. Moreover, this advance was accompanied by exceptionally high trading volume at 380% of normal. The stock has been […]
Revance Therapeutics Inc (NASDAQ: RVNC) stock enjoyed a major increase of 12.3% on 1/6/25. The shares closed at $3.47. Moreover, exceptionally high trading volume at 429% of normal accompanied the advance. Relative to the market […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research